Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 273956011000036111 | Zantac (ranitidine 150 mg) effervescent tablet, 30 tablets, tube (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 368141000036115 | Zantac 150 mg effervescent tablet, 30, tube | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Zantac 150 mg effervescent tablet, 30, tube | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Zantac 150 mg effervescent tablet, 30, tube | Is a | Zantac 150 mg effervescent tablet, 30 | true | Inferred relationship | Some | ||
| Zantac 150 mg effervescent tablet, 30, tube | has container type | tube | true | Inferred relationship | Some | ||
| Zantac 150 mg effervescent tablet, 30, tube | has TP | Zantac | true | Inferred relationship | Some | ||
| Zantac 150 mg effervescent tablet, 30, tube | has TPUU | Zantac 150 mg effervescent tablet | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Containered trade product pack reference set
FHIR